Sewoon Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	66,529	63,657	60,151	68,247	60,116	62,579
Other Revenue	-	-	-	-0	-	-
Revenue	66,529	63,657	60,151	68,247	60,116	62,579
Revenue Growth	10.39%	5.83%	-11.86%	13.53%	-3.94%	-1.80%
Cost of Revenue	41,292	40,112	37,963	40,689	37,896	37,522
Gross Profit	25,237	23,545	22,188	27,557	22,220	25,057
Selling, General & Admin	9,503	9,454	9,468	9,330	8,734	8,466
Research & Development	470.11	456.39	510.42	468.21	505.09	427.87
Amortization of Goodwill & Intangibles	221.86	242.33	149.71	143.91	152.41	87.82
Operating Expenses	10,905	10,844	10,811	10,637	10,033	9,671
Operating Income	14,332	12,701	11,377	16,920	12,187	15,386
Interest Expense	-31.16	-35.52	-36.63	-36.08	-35.81	-31.47
Interest & Investment Income	2,135	2,065	2,331	1,969	736.18	172.83
Currency Exchange Gain (Loss)	1,396	143.09	1,597	357.41	702.87	1,035
Other Non Operating Income (Expenses)	121.94	-7.96	73.35	69.67	38.25	67.05
EBT Excluding Unusual Items	17,954	14,865	15,342	19,280	13,629	16,630
Gain (Loss) on Sale of Assets	15.44	36.61	279.54	17.79	2.2	-0.67
Asset Writedown	-	-	-	-	-2	-2.96
Pretax Income	17,969	14,902	15,621	19,298	13,629	16,626
Income Tax Expense	3,466	2,709	3,046	3,824	2,990	3,864
Earnings From Continuing Operations	14,504	12,193	12,575	15,474	10,639	12,762
Net Income to Company	14,504	12,193	12,575	15,474	10,639	12,762
Minority Interest in Earnings	-606.06	-280.57	-412.61	-517.02	-232.69	-480.5
Net Income	13,897	11,912	12,163	14,957	10,406	12,282
Net Income to Common	13,897	11,912	12,163	14,957	10,406	12,282
Net Income Growth	37.14%	-2.06%	-18.68%	43.73%	-15.27%	17.02%
Shares Outstanding (Basic)	42	43	43	43	43	43
Shares Outstanding (Diluted)	42	43	43	43	43	43
Shares Change	-2.14%	-1.18%	-0.02%	-	-	-
EPS (Basic)	329.26	278.50	281.00	345.50	240.38	283.70
EPS (Diluted)	329.26	278.50	281.00	345.50	240.38	283.70
EPS Growth	40.13%	-0.89%	-18.67%	43.73%	-15.27%	17.02%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	14,295	16,083	11,750	21,127	7,128	19,244
Free Cash Flow Per Share	338.67	376.01	271.47	488.02	164.65	444.53
Dividend Per Share	-	-	-	70.000	60.000	50.000
Dividend Growth	-	-	-	16.67%	20.00%	0%
Gross Margin	37.93%	36.99%	36.89%	40.38%	36.96%	40.04%
Operating Margin	21.54%	19.95%	18.91%	24.79%	20.27%	24.59%
Profit Margin	20.89%	18.71%	20.22%	21.92%	17.31%	19.63%
Free Cash Flow Margin	21.49%	25.26%	19.54%	30.96%	11.86%	30.75%
EBITDA	17,601	16,021	14,857	20,568	16,075	19,222
EBITDA Margin	26.46%	25.17%	24.70%	30.14%	26.74%	30.72%
D&A For EBITDA	3,269	3,320	3,480	3,648	3,888	3,836
EBIT	14,332	12,701	11,377	16,920	12,187	15,386
EBIT Margin	21.54%	19.95%	18.91%	24.79%	20.27%	24.59%
Effective Tax Rate	19.29%	18.18%	19.50%	19.82%	21.94%	23.24%
Advertising Expenses	-	281.21	294.06	233.54	186.34	76.21